BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12042321)

  • 1. Mutational analysis of the hexose transporter of Plasmodium falciparum and development of a three-dimensional model.
    Manning SK; Woodrow C; Zuniga FA; Iserovich P; Fischbarg J; Louw AI; Krishna S
    J Biol Chem; 2002 Aug; 277(34):30942-9. PubMed ID: 12042321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hexose permeation pathways in Plasmodium falciparum-infected erythrocytes.
    Woodrow CJ; Burchmore RJ; Krishna S
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9931-6. PubMed ID: 10954735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraerythrocytic Plasmodium falciparum expresses a high affinity facilitative hexose transporter.
    Woodrow CJ; Penny JI; Krishna S
    J Biol Chem; 1999 Mar; 274(11):7272-7. PubMed ID: 10066789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthosteric-allosteric dual inhibitors of PfHT1 as selective antimalarial agents.
    Huang J; Yuan Y; Zhao N; Pu D; Tang Q; Zhang S; Luo S; Yang X; Wang N; Xiao Y; Zhang T; Liu Z; Sakata-Kato T; Jiang X; Kato N; Yan N; Yin H
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33402433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative characterization of hexose transporters of Plasmodium knowlesi, Plasmodium yoelii and Toxoplasma gondii highlights functional differences within the apicomplexan family.
    Joët T; Holterman L; Stedman TT; Kocken CH; Van Der Wel A; Thomas AW; Krishna S
    Biochem J; 2002 Dec; 368(Pt 3):923-9. PubMed ID: 12238947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Plasmodium vivax hexose transporters and effects of a parasitocidal inhibitor.
    Joët T; Chotivanich K; Silamut K; Patel AP; Morin C; Krishna S
    Biochem J; 2004 Aug; 381(Pt 3):905-9. PubMed ID: 15107012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Basis for Blocking Sugar Uptake into the Malaria Parasite Plasmodium falciparum.
    Jiang X; Yuan Y; Huang J; Zhang S; Luo S; Wang N; Pu D; Zhao N; Tang Q; Hirata K; Yang X; Jiao Y; Sakata-Kato T; Wu JW; Yan C; Kato N; Yin H; Yan N
    Cell; 2020 Oct; 183(1):258-268.e12. PubMed ID: 32860739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis for sugar import in malaria parasites.
    Qureshi AA; Suades A; Matsuoka R; Brock J; McComas SE; Nji E; Orellana L; Claesson M; Delemotte L; Drew D
    Nature; 2020 Feb; 578(7794):321-325. PubMed ID: 31996846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why is the Plasmodium falciparum hexose transporter a promising new drug target?
    Joët T; Morin C; Fischbarg J; Louw AI; Eckstein-Ludwig U; Woodrow C; Krishna S
    Expert Opin Ther Targets; 2003 Oct; 7(5):593-602. PubMed ID: 14498822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of parasite transporters in Xenopus oocytes.
    Krishna S; Woodrow CJ
    Novartis Found Symp; 1999; 226():126-39; discussion 139-44. PubMed ID: 10645543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An
    Altharawi A; Riadi Y; Tahir Ul Qamar M
    J Biomol Struct Dyn; 2023; 41(23):14450-14459. PubMed ID: 36812293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular docking, simulation and binding free energy analysis of small molecules as PfHT1 inhibitors.
    Owoloye AJ; Ligali FC; Enejoh OA; Musa AZ; Aina O; Idowu ET; Oyebola KM
    PLoS One; 2022; 17(8):e0268269. PubMed ID: 36026508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A constitutive pan-hexose permease for the Plasmodium life cycle and transgenic models for screening of antimalarial sugar analogs.
    Blume M; Hliscs M; Rodriguez-Contreras D; Sanchez M; Landfear S; Lucius R; Matuschewski K; Gupta N
    FASEB J; 2011 Apr; 25(4):1218-29. PubMed ID: 21169382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of O-(undec-10-en)-yl-D-glucose derivatives with the Plasmodium falciparum hexose transporter (PfHT).
    Ionita M; Krishna S; Léo PM; Morin C; Patel AP
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4934-7. PubMed ID: 17587575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the hexose transporter of Plasmodium falciparum as a novel drug target.
    Joet T; Eckstein-Ludwig U; Morin C; Krishna S
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7476-9. PubMed ID: 12792024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of
    Won JY; Mazigo E; Cha SH; Han JH
    Front Cell Infect Microbiol; 2023; 13():1321240. PubMed ID: 38282613
    [No Abstract]   [Full Text] [Related]  

  • 17. Probing structure/affinity relationships for the Plasmodium falciparum hexose transporter with glucose derivatives.
    Fayolle M; Ionita M; Krishna S; Morin C; Patel AP
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1267-71. PubMed ID: 16361099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of the Plasmodium falciparum hexose transporter and its therapeutic interventions.
    Jiang X
    Proteins; 2022 Oct; 90(10):1766-1778. PubMed ID: 35445447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of transmembrane segment 10 of the Glut1 glucose transporter by cysteine-scanning mutagenesis and substituted cysteine accessibility.
    Mueckler M; Makepeace C
    J Biol Chem; 2002 Feb; 277(5):3498-503. PubMed ID: 11713254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QLS motif in transmembrane helix VII of the glucose transporter family interacts with the C-1 position of D-glucose and is involved in substrate selection at the exofacial binding site.
    Seatter MJ; De la Rue SA; Porter LM; Gould GW
    Biochemistry; 1998 Feb; 37(5):1322-6. PubMed ID: 9477959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.